Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Aerts

Showing results (321-330 of 337) with videos related to

Pageof 34
Sort By:
Chemical Science|November 17, 2017
<i>In vitro</i> and <i>in vivo</i> comparative and competitive activity-based protein profiling of GH29 α-l-fucosidasesJianbing Jiang, Wouter W Kallemeijn, Daniel W Wright, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugarsAmar Ghisaidoobe, Pieter Bikker, Arjan C J de Bruijn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 17, 2022
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape projectJan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
Cancer Cell|October 2, 2020
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph NodesFloris Dammeijer, Mandy van Gulijk, Evalyn E Mulder, et al.
Journal of the American Chemical Society|July 2, 2020
Manno-<i>epi</i>-cyclophellitols Enable Activity-Based Protein Profiling of Human α-Mannosidases and Discovery of New Golgi Mannosidase II InhibitorsZachary Armstrong, Chi-Lin Kuo, Daniël Lahav, et al.
Angewandte Chemie (International Ed. in English)|November 10, 2012
Novel activity-based probes for broad-spectrum profiling of retaining β-exoglucosidases in situ and in vivoWouter W Kallemeijn, Kah-Yee Li, Martin D Witte, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2026
Oseltamivir aziridines are potent influenza neuraminidase inhibitors and imaging agentsMerijn B L Vriends, Elisha Moran, Martín Calvelo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2022
Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I studyS P Lau, L Klaase, M Vink, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2020
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 PandemicAnne-Marie C Dingemans, Ross A Soo, Abdul Rahman Jazieh, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancerWouter W Mellema, Lucie Masen-Poos, Egbert F Smit, et al.
Pageof 34

Showing results (321-330 of 337) with videos related to

Sort By:
Pageof 34
Chemical Science|November 17, 2017
<i>In vitro</i> and <i>in vivo</i> comparative and competitive activity-based protein profiling of GH29 α-l-fucosidasesJianbing Jiang, Wouter W Kallemeijn, Daniel W Wright, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugarsAmar Ghisaidoobe, Pieter Bikker, Arjan C J de Bruijn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 17, 2022
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape projectJan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
Cancer Cell|October 2, 2020
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph NodesFloris Dammeijer, Mandy van Gulijk, Evalyn E Mulder, et al.
Journal of the American Chemical Society|July 2, 2020
Manno-<i>epi</i>-cyclophellitols Enable Activity-Based Protein Profiling of Human α-Mannosidases and Discovery of New Golgi Mannosidase II InhibitorsZachary Armstrong, Chi-Lin Kuo, Daniël Lahav, et al.
Angewandte Chemie (International Ed. in English)|November 10, 2012
Novel activity-based probes for broad-spectrum profiling of retaining β-exoglucosidases in situ and in vivoWouter W Kallemeijn, Kah-Yee Li, Martin D Witte, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2026
Oseltamivir aziridines are potent influenza neuraminidase inhibitors and imaging agentsMerijn B L Vriends, Elisha Moran, Martín Calvelo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2022
Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I studyS P Lau, L Klaase, M Vink, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2020
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 PandemicAnne-Marie C Dingemans, Ross A Soo, Abdul Rahman Jazieh, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancerWouter W Mellema, Lucie Masen-Poos, Egbert F Smit, et al.
Pageof 34